
Virupaksha Organics Ltd. has emerged as a leader in the pharmaceutical industry, specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs). Founded in 2003, the company has built a reputation for innovation, quality, and sustainability. Under the dynamic leadership of Mr. Chandra Mouliswar Reddy Gangavaram, Virupaksha has grown its operations significantly, with state-of-the-art manufacturing facilities in Telangana, India.
The company’s facilities in Kazipally and Pashamylaram are certified by international and national regulatory bodies, including ISO 9001, ISO 14001, ISO 45001, ISO 50001, and GMP standards, ensuring that Virupaksha meets the highest levels of quality and safety in its production processes. These certifications highlight the company’s commitment to environmental sustainability, occupational safety, and best industry practices.
Virupaksha Organics is committed to excellence, innovation, and customer satisfaction, with a focus on developing sustainable solutions for the pharmaceutical industry. The company’s products are trusted by major pharmaceutical firms globally, as it continues to make strides towards becoming a research-driven organization. With a forward-thinking management team and a clear vision for the future, Virupaksha Organics is poised for rapid growth and continues to play a key role in advancing global healthcare.
As part of its corporate social responsibility (CSR), Virupaksha has initiated numerous welfare programs aimed at uplifting local communities and supporting environmental conservation, reinforcing its reputation as a responsible corporate citizen.
With continuous advancements and strategic partnerships, Virupaksha Organics Ltd. is well-positioned to expand its global footprint and contribute to the evolving pharmaceutical landscape.

Other Latest News
- <![CDATA[Trial Data Show Significant EFS and OS in Patients with Muscle-Invasive Bladder Cancer ]]> Targeted Oncology Targeted Oncology: What was the rationale or unmet needs that prompted this line of research? Christof Vulsteke, MD, PhD: Two years ago, also at ESMO, we presented groundbreaking results of perioperative pembrolizumab in a metastatic setting. There, we saw …
- <![CDATA[FDA Prioritizes sBLA Review for Enfortumab Vedotin/Pembro in MIBC]]> Targeted Oncology “The topline results of the study for [EFS] were a strong hit as a primary end point. There was an early and sustained separation of the [Kaplan-Meier] curves in favor of pembrolizumab, and this was translated in a significant hazard ratio of 0.4,” said …
- RAMM Pharma Corp. Provides Update on Canada post strike and mailing of the Company´s meeting materials EIN Presswire TORONTO, Oct. 22, 2025 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), wishes to notify shareholders that a disruption due to the ongoing Canada Post strike (the “Postal Strike …
- Indian Pharma Supplier Plans $200M Capsule Factory in Atlanta Global Atlanta - Georgia An India-based pharmaceutical machinery firm selling in the U.S. for 25 years has chosen metro Atlanta for a $200 million bet on American manufacturing. ACG, headquartered in Mumbai with sales in 138 countries, plans to hire 200 people as it introduces a …
- <![CDATA[FDA Grants Priority Review to Enfortumab Vedotin Combo in MIBC Subset]]> Cancer Network - New Jersey The pathologic complete response (pCR) rate with the experimental therapy was 57.1% (95% CI, 49.3%-64.6%) compared with 8.6% (95% CI, 4.9%-13.8%) with the control therapy, with an estimated difference of 48.3% (95% CI, 39.5%-56.5%; P <.000001). In a …
- Bragar Eagel & Squire, P.C. Reminds Investors of aTyr, Marex, Cepton, and MoonLake to Contact the Firm About their Rights in Filed Class Action Lawsuits EIN Presswire NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of aTyr Pharma, Inc. (NASDAQ:ATYR), Marex …
- aTyr Pharma, Inc.’s (ATYR) Failed Drug Trial Spurs Securities Lawsuit -- Hagens Berman EIN Presswire SAN FRANCISCO, Oct. 22, 2025 (GLOBE NEWSWIRE) -- A federal class-action lawsuit has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) following a devastating 83% drop in the biotech company’s stock price after its lead drug candidate failed to meet its …
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of aTyr Pharma, Inc.(ATYR) Shareholders EIN Presswire NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of aTyr Pharma, Inc. (NASDAQ: ATYR). Shareholders who purchased shares of ATYR during the class period listed are encouraged to contact the firm …
- Automated Liquid Handling Systems Market Industry Trends and Forecasts to 2035 | Rising Demand for Automated Pipetting and Microplate Washing Technologies in Pharma Labs - ResearchAndMarkets.com Voice of Alexandria - Minnesota DUBLIN--(BUSINESS WIRE)--Oct 22, 2025-- The "Automated Liquid Handling Systems Market Industry Trends and Global Forecasts to 2035: Distribution by Pipetting Technology, Washing Technology, Modality Type of Instrument, Application, End User and Key …
- Telix Doses First Patient in SOLACE Trial for Metastatic Bone Pain EIN Presswire MELBOURNE, Australia and INDIANAPOLIS, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that it has dosed the first patient in a Phase 1 clinical trial of TLX090 (153Samarium (Sm)-DOTMP), a …
- Stock market index up 1.15% STA Ljubljana, 22 October - The SBI TOP benchmark index of the Ljubljana Stock Exchange gained 1.15% to close at 2,536.10 points on Wednesday, as the majority of the blue chips posted gains. Total turnover stood at EUR 6.9 million, with pharma company Krka, …
- <![CDATA[Pharma Pulse: Telehealth Medication Abortion Requests Surge, FDA Expedites Tzield Review, and New Biopharma Air Network Launches]]> Pharmaceutical Commerce Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and today we’re covering the surge in …
- <![CDATA[Mark Cuban Confirms Cost Plus Drugs Partnership ]]> Pharmaceutical Commerce At the HLTH conference’s keynote in Las Vegas, Mark Cuban—entrepreneur and co-founder of Cost Plus Drugs—confirmed that his company will be collaborating with TrumpRx, President Trump’s direct purchasing platform.1 The businessman hasn’t been shy about …
- Eat the Rainbow: Why Food-Based Antioxidants Beat Pills for Longevity, Vitality, and Disease Prevention Natural News Eat the Rainbow: Why Food-Based Antioxidants Beat Pills for Longevity, Vitality, and Disease Prevention When it comes to describing what an antioxidant is, it’s all in the name: antioxidant—it fights oxidation. And that’s a very good thing. Oxidants, …
- <![CDATA[First UAE Patient Enrolled in Medicus' Trial for Non-Invasive BCC Therapy]]> Dermatology Times Medicus Pharma has announced the treatment of the first patient in the United Arab Emirates (UAE) as part of its SKNJCT-004 phase 2 clinical trial.1 The study investigates a novel, non-invasive treatment approach for basal cell carcinoma (BCC) of the skin …
- Inside Dow Jones: Key Earnings Ahead for Some of the Index YTD Winners Investing Caterpillar shares have jumped to a sizable lead among the Dow 30 YTD, and the Texas company reports Q3 results next week Johnson & Johnson, NVIDIA, and Goldman Sachs are in a race for the second spot, each with a unique momentum story ongoing …
- Fox News viewers beg Karoline Leavitt to 'see a psychologist' after 'insane lies' Irish Star 07:43 ET, 22 Oct 2025Updated 09:35 ET, 22 Oct 2025 Fox News fans demand Karoline Leavitt see a 'psychologist' after her recent appearance(Image: Fox News) Karoline Leavitt's recent appearance on Fox News has sparked a flurry of concern among …
- <![CDATA[FDA grants priority review to sBLA for EV plus pembrolizumab in cisplatin-ineligible MIBC]]> Urology Times On October 22, 2025, Astellas announced that the FDA granted priority review to a supplemental biologics license application (sBLA) for a perioperative regimen of enfortumab vedotin-ejfv (Padcev) plus pembrolizumab (Keytruda) for patients with muscle- …
- Ten Ways You Are Being Burned by Billionaires The Good Men Project - California By Chuck Collins As a co-editor of Inequality.org, I get a lot of fan mail (and a few complaints). Greg B. recently wrote in, “None of my problems exist as a result of someone else being a billionaire.” My response to Greg: “An economy rigged to funnel …
- Former Sen. John Sununu announces New Hampshire Senate run Boston 25 News - Massachusetts NEW HAMPSHIRE — Former Senator. John Sununu is looking to head back to Washington Sununu announced in a campaign video posted to Facebook that he will be running for U.S Senate in New Hampshire. “It’s been a while since you elected me to serve New …
- ICH E6(R3) in effect: transforming quality management for cell and gene therapy trials Pharmaceutical Technology This long-awaited guideline will revolutionise clinical trial management across life sciences, giving CGT developers a regulatory framework that finally matches the speed and flexibility their groundbreaking therapies demand. Perfect timing, too. The CGT …
- ADCs: A Primer for the Pharmaceutical Industry Pharmaceutical Technology ADCs are precision medicines that hitch a cell-killing drug (the “payload”) to an antibody via a chemical “linker”. The antibody ferries the payload to cells bearing a targeted protein on their surface; once inside, the linker breaks and releases the drug. …
- The future of high-potency APIs: Strategies for manufacturing challenges Pharmaceutical Technology The growing friction between the US and China has serious consequences for the supplies of high-potency active pharmaceutical ingredients (HPAPIs), with pharmaceutical companies facing uncertainty around the stability of their supply chains and tariff- …
- Development opportunities showcased at Regional Investment Summit were 'brilliant to see' says leading business figure Express & Star The summit, held at Edgbaston Cricket Ground, Birmingham, on Tuesday (October 21) saw £800 million of investment for the West Midlands announced, which will create hundreds of jobs and boost skills across the region. More than 350 business leaders, …
- Relatives of the 124 victims of adulterated fentanyl in Argentina demand justice: ‘This is an unprecedented massacre’ El País The first warning signs appeared in the corridors of the intensive care unit. “Many are dying,” the relatives of patients admitted to the Italian Hospital in La Plata, about 35 miles south of Buenos Aires, whispered. It was early April, and everyone feared …
- Behind the Headlines Episode 27: Unpacking Mega Deals and R&D Directions Pharmaceutical Technology Behind the Headlines bi-weekly episodes examine the ongoing trends, factors, and fashions that cause pharmaceutical news to happen. Panelists are a mix of consultants, venture capitalists, scientists, patient advocates, journalists, and editors. Each …
- SAP Scales Agentic AI for Autonomous Customer Support Efficiency WebProNews In the rapidly evolving world of enterprise software, SAP SE is making bold strides to integrate agentic artificial intelligence into its customer support operations, promising to redefine how businesses interact with technical assistance. According to a …
- STAT+: Novo Foundation ousts board in power struggle STAT - Massachusetts Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning! Today, we talk about how startups are looking for new ways to price drugs, particularly GLP-1s, see how tracking …
- STAT+: Pharmalittle: We’re reading about a new Trump drug-pricing probe, Novo’s board shake-up, and more STAT - Massachusetts Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the …
- Aurangzeb ‘quite hopeful’ Pakistan can achieve close to 3.5pc GDP growth during ongoing fiscal year Dawn <p>Finance Minister Muhammad Aurangzeb has said he is “quite hopeful” that Pakistan could manage to achieve GDP growth of close to 3.5 per cent during the ongoing fiscal year despite the impact of recent floods.</p> <p>The finance …
- What it’s like to job hunt in Greater Boston right now, according to readers Boston.com - Massachusetts Readers Say From endless applications to small victories, readers reveal what job hunting in Greater Boston really feels like right now. Readers reveal what job hunting in Greater Boston really feels like right now. David L Ryan/Globe Staff By Annie …
- Migraine Drugs Market Projected to Surpass USD 15.54 billion by 2032 Due to Rising Demand – SNS Insider Business Upturn NS Insider projects the US market to reach USD 5.80 billion by 2032, driven by increasing prevalence and innovative therapies Austin, Oct. 22, 2025 (GLOBE NEWSWIRE) — Migraine Drugs Market Size & Growth Analysis: According to S&S Insider, the …
- USD flat, GBP hit after UK's inflation report and XAU resumes recent downside - Newsquawk US Opening News Zero Hedge European bourses are broadly lower, but FTSE 100 outperforms after UK inflation; US equity futures are modestly weaker. USD is flat & GBP hit after region's softer-than-expected inflation report, which has boosted bets for a cut in December. USTs …
- Futures Flat As Gold Selloff Extends Zero Hedge US equity futures are flat again, with tech and small caps lagging as traders parsed the latest earnings reports and corporate news amid worries over trade, the US government shutdown and geopolitical risks. Gold and silver extended declines after Tuesday’ …
- Here’s why you should stay invested in the stock market and follow the basics this new Vikram Samvat Mint In the 14 months I have been writing this column, I felt compelled to address current market conditions only once before. In ‘Stay put or exit? What should investors do in this market slump,’ (27 February 2025), I wrote, “In short, currently it is time to …
- How India survived global uncertainty and cut inflation The Week India’s economy showed remarkable strength in the second quarter of 2025-26, as inflation dropped to its lowest level since 2017. The best part? This came during a time of mounting global trade tensions and policy uncertainties that created headwinds for …
- Galapagos to shutter cell and gene therapy unit Pharmaceutical Technology Galapagos NV is winding down its cell and gene therapy (CGT) division after an unsuccessful attempt to sell the unit, becoming the latest biotech to retreat from a sector that has lost momentum after a period of intense investment. The Belgian biotech said …
- Full list of companies fined for failing to pay National Minimum Wage Wales Online Millions of pounds have been repaid to the affected workers(Image: GETTY) Almost 500 employers, including some well-known high street and luxury brands, have been fined more than £10 million for not paying the National Minimum Wage. Around 42,000 workers, …
- Fox News viewers demand Karoline Leavitt see a 'psychologist' after 'insane' interview The Mirror US Some of the comments made by Karoline Leavitt during her latest Fox News appearance had fans begging her to get some psychiatric help. Donald Trump's press secretary, 28, was a guest on Fox News' Jesse Watters Primetime to discuss the latest goings …
- Biotech Markets Turn Positive but Experts Say Don’t Call It a Comeback—Yet BioSpace Finally, after years of brutal recalibration, multiple biotech market biomarkers are starting to trend in the right direction. M&A has returned; the S&P Biotech ETF (XBI) has climbed 43% in six months; multiple biotechs have issued positive, …
- He exposed My Lai and Abu Ghraib. Now 'Cover-Up' turns the lens on Seymour Hersh Los Angeles Times For more than half a century, Seymour Hersh has been asking the questions the powerful would rather not answer. As one of America’s most relentless investigative reporters, he exposed the 1968 massacre of hundreds of Vietnamese civilians — including …
- Former GOP senator emerges from private sector with new mission: 'Somebody has to step up' Fox News Former Republican Sen. John E. Sununu of New Hampshire, in a Fox News Digital interview, looks ahead to a potential 2026 Senate bid in swing state New Hampshire and says,"This is a race that can be won." NEWYou can now listen to Fox News articles …
- API China returns with 93rd edition to strengthen its role as Asia’s pharma powerhouse Biospectrum Asia API China returns with 93rd edition to strengthen its role as Asia’s pharma powerhouse October 22, 2025 | Wednesday | News One of the largest gatherings of the pharmaceutical supply chain is staged at the Chongqing International Expo Center from 12–14 …
- Five things for pharma marketers to know for Wednesday, October 22, 2025 Medical Marketing and Media Mark Cuban said his pharmacy brand Cost Plus Drugs will partner with TrumpRx. Cuban shared the news during his keynote at the HLTH conference. (Endpoints News) Gilead said that it has agreed not to increase the price of HIV medication for state-based AIDS …
- Mukul Agrawal on a shopping spree in Q2FY26; adds 10 fresh stocks, raises stakes in 5 more Business Today Ace investor Mukul Mahavir Agrawal has been on a shopping spree in the second quarter ended on September 30, 2025 as the seasoned Dalal Street veteran has added at least ten new stocks in his portfolio. His name appeared in the key shareholder's list …
- Political Speech and the Public Square debates the benefits and drawbacks of AI The Michigan Daily The University Insider is The Daily’s first faculty and staff-oriented newsletter. This weekly newsletter will give U-M faculty and staff the ability to see the most important issues on campus and in Ann Arbor — particularly those related to administrative …
- How to slash a drug price by 97 per cent Down to Earth The judgements have come in fairly quick succession, and they have directly or indirectly put patients first by prioritising the need for more affordable medicines. Not just the courts but the Patent Office has reminded drug multinationals that the laws …
- CCI clears second largest deal ever in pharma sector, more details Business Today Torrent Pharmaceuticals has received clearance from the Competition Commission of India (CCI) for its proposed acquisition of a significant stake in JB Chemicals & Pharmaceuticals. "The Commission approved the proposed combination subject to …
- FOMO meets FOWO in edgy markets: Mike Dolan Zawya LONDON - Investors' long-held "fear of missing out" is now vying with their "fear of wipeout", creating a peculiar situation in which there are simultaneously anxieties about all the risks that could upset today's stretched …
- Stock Market Holiday Today, October 22: NSE, BSE Closed for Bali Pratipada 2025, Trading to Resume on October 23 Latestly Mumbai, October 22: Indian stock markets remained closed on Wednesday on account of the festival holiday of Bali Pratipada. As per the official NSE holiday calendar, the markets are shut for today, and trading will resume on Thursday. Bali Pratipada is an …